Advisornet Financial’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Advisornet Financial’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-750	Closed	-$89K	–	1886
2020 Q4	$89K	Hold	750	–	–	0.01%	728
2020 Q3	$83K	Hold	750	–	–	0.01%	725
2020 Q2	$77K	Hold	750	–	–	0.01%	745
2020 Q1	$81K	Hold	750	–	–	0.01%	663
2019 Q4	$87K	Hold	750	–	–	0.01%	725
2019 Q3	$86K	Hold	750	–	–	0.01%	724
2019 Q2	$71K	Hold	750	–	–	0.01%	706
2019 Q1	$68K	Hold	750	–	–	0.01%	658
2018 Q4	$57K	Buy	+750	New	+$55.2K	0.01%	659
2018 Q3	–	Sell	-910	Closed	-$90K	–	1696
2018 Q2	$90K	Hold	910	–	–	0.01%	553
2018 Q1	$74K	Hold	910	–	–	0.01%	603
2017 Q4	$72K	Buy	+910	New	+$75.7K	0.01%	558

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Advisornet Financial's CBPO Position: Q1 2021 in Review

Advisornet Financial sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2021, closing a stake of 750 shares — an estimated $89K sold.

Advisornet Financial first reported a position in CBPO in Q4 2017 and held it in 12 quarters. The position peaked at $90K in Q2 2018. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.

Advisornet Financial reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
Advisornet Financial sold 750 China Biologic Products Holdings, Inc. shares in Q1 2021, an estimated $89K.
Advisornet Financial first reported a position in China Biologic Products Holdings, Inc. in Q4 2017 and held it in 12 quarters.
Advisornet Financial's China Biologic Products Holdings, Inc. position peaked at $90K in Q2 2018.
86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.

Based on Advisornet Financial's 13F filing for Q1 2021, filed 14 Apr 2021.